Who Supplies Valacyclovir? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Valacyclovir exports, with 113+ registered manufacturers shipping to buyers across 70+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 36.1% (export value: $33.7M). Close behind, HETERO LABS LIMITED (13.7%, $12.8M). AUROBINDO PHARMA LTD (1.7%, $1.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Valacyclovir? Top Manufacturers & Their Buyers
Flow of Valacyclovir from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Valacyclovir Supplier Network — Key Market Intelligence
The Valacyclovir export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 36.1% share, shipping $33.7M worth of product across 62 shipments. The second-largest exporter, HETERO LABS LIMITED, contributes $12.8M (13.7%) to the overall market. Combined, the top two suppliers alone account for 49.9% of all Valacyclovir exports, indicating a relatively concentrated supply base.
Across all 113 tracked manufacturers, the total Valacyclovir export value stands at $93.2M from 2.5K shipments. The market average shipment value is $36.7K. The single largest buyer relationship in terms of trade value is MYLAN PHARMACEUTICALS ULC, receiving $16.2M worth of product.
The combined buyer network spans 9 named purchasing companies, including MYLAN PHARMACEUTICALS ULC, VIATRIS PHARMACEUTIC, XXMBEXXPHAXXACEXXICAXX IXX, XXNDOXXPTYXXTD, NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS and 4 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Valacyclovir exporter from India, with a market share of 36.1% and a total export value of $33.7M across 62 shipments. Their average shipment value of $543.0K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN PHARMACEUTICALS ULC — $16.2M across 30 shipments (48.2% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $13.1M across 24 shipments (39.0% of this supplier's total exports)
• VIATRIS PHARMACEUTIC — $2.9M across 5 shipments (8.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $992.8K across 2 shipments (2.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS ULC — $441.9K across 1 shipments (1.3% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $543.0K is 1378% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
2HETERO LABS LIMITED
HETERO LABS LIMITED is the second-largest Valacyclovir exporter from India, with a market share of 13.7% and a total export value of $12.8M across 251 shipments. Their average shipment value of $51.0K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
HETERO LABS LIMITED serves 5 named buyers in our database. XXMBEXXPHAXXACEXXICAXX IXX is the dominant customer, accounting for 72.4% of this supplier's tracked business. Top customers include:
• XXMBEXXPHAXXACEXXICAXX IXX — $9.3M across 182 shipments (72.4% of this supplier's total exports)
• TO THE ORDER OF — $2.8M across 55 shipments (21.7% of this supplier's total exports)
• TO — $305.4K across 6 shipments (2.4% of this supplier's total exports)
• XXNDOXXPTYXXTD — $284.5K across 6 shipments (2.2% of this supplier's total exports)
• TO THE ORDER — $155.8K across 3 shipments (1.2% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED's per-shipment value of $51.0K is 39% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
3AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the third-largest Valacyclovir exporter from India, with a market share of 1.7% and a total export value of $1.6M across 41 shipments. Their average shipment value of $39.5K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LTD serves 3 named buyers in our database. NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS is the dominant customer, accounting for 61.0% of this supplier's tracked business. Top customers include:
• NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS — $988.0K across 25 shipments (61.0% of this supplier's total exports)
• AURO PHARMA INC — $408.6K across 10 shipments (25.2% of this supplier's total exports)
• AURO PHARMA INC — $222.3K across 6 shipments (13.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $39.5K is 8% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
4V S INTERNATIONAL PRIVATE LIMITED
V S INTERNATIONAL PRIVATE LIMITED is the fourth-largest Valacyclovir exporter from India, with a market share of 1.3% and a total export value of $1.2M across 37 shipments. Their average shipment value of $33.5K is below the market average of $36.7K, reflecting a high-volume, competitive pricing strategy.
V S INTERNATIONAL PRIVATE LIMITED serves 2 named buyers in our database. JAMP PHARMA CORPORATION is the dominant customer, accounting for 86.5% of this supplier's tracked business. Top customers include:
• JAMP PHARMA CORPORATION — $1.1M across 32 shipments (86.5% of this supplier's total exports)
• JAMP PHARMA CORPORATION — $168.0K across 5 shipments (13.5% of this supplier's total exports)
Key Insight: V S INTERNATIONAL PRIVATE LIMITED operates with high shipment frequency (37 shipments) at a per-shipment value of $33.5K, indicating a broad distribution network with many smaller, regular orders.
5AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the fifth-largest Valacyclovir exporter from India, with a market share of 1.0% and a total export value of $935.5K across 4 shipments. Their average shipment value of $233.9K is above the market average of $36.7K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LIMITED serves 2 named buyers in our database. NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS is the dominant customer, accounting for 75.3% of this supplier's tracked business. Top customers include:
• NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS — $704.8K across 3 shipments (75.3% of this supplier's total exports)
• AURO PHARMA INC — $230.7K across 1 shipments (24.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $233.9K is 537% above the market average of $36.7K, consistent with large-order contracts or value-added formulations.
6CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Valacyclovir exporter from India, with a market share of 0.3% and a total export value of $325.0K across 15 shipments. Their average shipment value of $21.7K is below the market average of $36.7K, reflecting a high-volume, competitive pricing strategy.
CIPLA LIMITED serves 2 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the dominant customer, accounting for 57.7% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $187.4K across 9 shipments (57.7% of this supplier's total exports)
• SUCCESS INTER LINK P — $137.5K across 6 shipments (42.3% of this supplier's total exports)
Key Insight: CIPLA LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $21.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Valacyclovir Flows
Once Valacyclovir leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED, it travels to 5 destination markets with a combined import value of $93.2M. United States absorbs the largest share at 87.2% ($81.2M), followed by Canada (4.0%) and Taiwan (3.3%).
In United States — the top destination — named importers include MYLAN PHARMACEUTICALS INC,, MYLAN PHARMACEUTICALS INC, XXMBEXXPHAXXACEXXICAXX IXX. In Canada, key buyers are JAMP PHARMA CORPORATION, MYLAN PHARMACEUTICALS ULC, AURO PHARMA INC.
This geographic spread reflects Valacyclovir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Valacyclovir Go? Top Importing Countries & Their Buyers
Trade flow of Valacyclovir exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Valacyclovir imports from India, with a total trade value of $81.2M across 189 shipments — representing a 87.2% share of all Valacyclovir exports. The average shipment value of $429.8K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.
Named Valacyclovir importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 25.3% ($20.5M) of this market's total imports.
• MYLAN PHARMACEUTICALS INC, — $20.5M (25.3% of United States's total)
• MYLAN PHARMACEUTICALS INC — $14.9M (18.3% of United States's total)
• XXMBEXXPHAXXACEXXICAXX IXX — $9.3M (11.4% of United States's total)
Key Insight: United States's per-shipment average of $429.8K (1070% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Valacyclovir imports from India.
2Canada
Canada ranks as the second-largest destination for Valacyclovir imports from India, with a total trade value of $3.7M across 44 shipments — representing a 4.0% share of all Valacyclovir exports. The average shipment value of $83.7K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Valacyclovir importers in Canada: JAMP PHARMA CORPORATION is the largest buyer, accounting for 35.7% ($1.3M) of this market's total imports.
• JAMP PHARMA CORPORATION — $1.3M (35.7% of Canada's total)
• MYLAN PHARMACEUTICALS ULC — $992.8K (26.9% of Canada's total)
• AURO PHARMA INC — $639.3K (17.4% of Canada's total)
Key Insight: Canada's per-shipment average of $83.7K (128% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Valacyclovir imports from India.
3Taiwan
Taiwan ranks as the third-largest destination for Valacyclovir imports from India, with a total trade value of $3.0M across 0 shipments — representing a 3.3% share of all Valacyclovir exports. The average shipment value of $3.0M is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Taiwan's per-shipment average of $3.0M (8197% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Taiwan is a key market for Valacyclovir imports from India.
4Sweden
Sweden ranks as the fourth-largest destination for Valacyclovir imports from India, with a total trade value of $1.9M across 0 shipments — representing a 2.0% share of all Valacyclovir exports. The average shipment value of $1.9M is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sweden's per-shipment average of $1.9M (4967% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sweden is a key market for Valacyclovir imports from India.
5Saudi Arabia
Saudi Arabia ranks as the fifth-largest destination for Valacyclovir imports from India, with a total trade value of $611.4K across 7 shipments — representing a 0.7% share of all Valacyclovir exports. The average shipment value of $87.3K is above the global average of $36.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valacyclovir importers in Saudi Arabia: SAUDI AMAROX FOR INDUSTRY COMPANY is the largest buyer, accounting for 91.0% ($556.4K) of this market's total imports.
• SAUDI AMAROX FOR INDUSTRY COMPANY — $556.4K (91.0% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $87.3K (138% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Valacyclovir imports from India.
People Also Ask — Valacyclovir Supplier & Trade Network
Who are the top suppliers of Valacyclovir from India?+
Which companies buy Valacyclovir from Indian manufacturers?+
Where does Valacyclovir exported from India go?+
What is the market share of the top Valacyclovir supplier from India?+
What is the average shipment value for Valacyclovir exports from India?+
Is Valacyclovir manufactured in India and exported globally?+
Which country imports the most Valacyclovir from India?+
Who are the buyers of Valacyclovir in Canada?+
How concentrated is the Valacyclovir supplier market in India?+
How do I find verified buyers for Valacyclovir in specific countries?+
Valacyclovir Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Valacyclovir exporter with a 36.1% market share and $33.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 113 suppliers collectively account for 54.3% of all tracked Valacyclovir exports, with a combined trade value of $93.2M.
- 3United States is the largest destination market, absorbing 87.2% of India's Valacyclovir exports ($81.2M). Canada (4.0%) and Taiwan (3.3%) follow.
- 4With 2.5K total shipments averaging $36.7K each, the Valacyclovir export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN PHARMACEUTICALS ULC, MYLAN PHARMACEUTICALS ULC, XXMBEXXPHAXXACEXXICAXX IXX, XXNDOXXPTYXXTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 70 countries
Network value: $93.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valacyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Valacyclovir.
- 2.Flow Mapping: 113 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,537 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 70 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,537 Verified Shipments
113 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists